Journal of Affective Disorders
Volume 75, Issue 1 , Pages 65-69 , June 2003

Studies on serotonergic markers in the human hippocampus: changes in subjects with bipolar disorder

Received 23 April 2001 ,Revised 18 December 2001 ,Accepted 4 January 2002.

References 

  1. Benes FM, Kwok EW, Vincent SL, Todtenkopf MS. A reduction of non-pyramidal cells in sector CA2 of schizophrenics and manic depressives. Biol. Psychiatry. 1998;44:88–97
  2. Biegon A, Kargman S, Snyder L, McEwen BS. Characterization and localization of serotonin receptors in human brain post-mortem. Brain Res. 1986;363:91–98
  3. Cortes R, Soriano E, Pazos A, Probst A, Palacios JM. Autoradiography of anti-depressant binding sites in the human brain: localization using [3H]imipramine and [3H]paroxetine. Neuroscience. 1988;27:473–496
  4. Dean B, Opeskin K, Pavey G, Naylor L, Hill C, Keks N, et al. The [3H]paroxetine binding is altered in the hippocampus but not the frontal cortex or caudate nucleus from subjects with schizophrenia. J. Neurochem. 1995;64:1197–1202
  5. Dean B, Pavey G, McLeod M, Opeskin K, Keks N, Copolov DL. A change in the density of [3H]flumazenil, but not [3H]muscimol binding, in Brodmann’s area 9 from subjects with bipolar disorder. J. Affect. Disord. 2000;66:147–158
  6. Disbrey BD, Rack JH. Histological Laboratory Methods. Edinburgh: E and S Livingstone; 1970;
  7. Drevets WC, Frank E, Price JC, Kupfer DJ, Holt D, Greer PJ, et al. PET imaging of serotonin 1A receptor binding in depression. Biol. Psychiatry. 1999;46:1375–1387
  8. Duncan GE, Little KY, Kirkman JA, Kaldas RS, Stumpf WE, Breese GR. Autoradiographic characterization of [3H]imipramine and [3H]citalopram binding in rat and human brain: species differences and relationships to serotonin innervation patterns. Brain Res. 1992;591:181–197
  9. Eastwood SL, Harrison PJ. Hippocampal synaptic pathology in schizophrenia, bipolar disorder and major depression: a study of complexin mRNAs. Mol. Psychiatry. 2000;5:425–432
  10. Gross-Isseroff R, Israeli M, Biegon A. Autoradiographic analysis of tritiated imipramine binding in the human brain post-mortem: effects of suicide. Arch. Gen. Psychiatry. 1989;46:237–241
  11. Gross-Isseroff R, Salama D, Israeli M, Biegon A. Autoradiographic analysis of age-dependent changes in serotonin 5-HT2 receptors of the human brain post-mortem. Brain Res. 1990;519:223–227
  12. Gruzelier J, Seymour K, Wilson L, Jolley A, Hirsch S. Impairments on neuropsychologic tests of temporohippocampal and frontohippocampal functions and word fluency in remitting schizophrenia and affective disorders. Arch. Gen. Psychiatry. 1988;45:623–629
  13. Hall H, Lundkvist C, Halldin C, Farde L, Pike VW, McCarron JA, et al. Autoradiographic localization of 5-HT1A receptors in the post-mortem human brain using [3H]WAY-100635 and [11C]way-100635. Brain Res. 1997;745:96–108
  14. Hoyer D, Pazos A, Probst A, Palacios JM. Serotonin receptors in the human brain. I. Characterization and autoradiographic localization of 5-HT1A recognition sites. Apparent absence of 5-HT1B recognition sites. Brain Res. 1986;376:85–96
  15. Kohler C, Radesater AC, Lang W, Chan-Palay V. Distribution of serotonin-1A receptors in the monkey and the post-mortem human hippocampal region. A quantitative autoradiographic study using the selective agonist [3H]8-OH-DPAT. Neurosci. Lett. 1986;72:43–48
  16. Mahmood T, Silverstone T. Serotonin and bipolar disorder. J. Affect. Disord. 2001;66:1–11
  17. Naylor L, Dean B, Opeskin K, Hill C, Keks NA, Copolov DL. Possible conformational changes in the serotonin transporter in the hippocampus of subjects with schizophrenia identified using [3H]paroxertine. J. Neural Transm. Gen. Sect. 1996;103:749–757
  18. Pascual J, del Arco C, Romon T, del Olmo E, Castro E, Pazos A. Autoradiographic distribution of [3H]sumatriptan-binding sites in post-mortem human brain. Cephalalgia. 1996;16:317–322
  19. Pauwels PJ. 5-HT 1B/D receptor antagonists. Gen. Pharmacol. 1997;29:293–303
  20. Plenge P, Mellerup ET. The [3H]citalopram binding to brain and platelet membranes of human and rat. J. Neurochem. 1991;56:248–252
  21. Scarr E, Copolov DL, Dean B. A proposed pathological model in the hippocampus of subjects with schizophrenia. Clin. Exp. Pharmacol. Physiol. 2001;28:70–73
  22. Soares JC, Mann JJ. The anatomy of mood disorders—Review of structural neuroimaging studies. Biol. Psychiatry. 1997;41:86–106
  23. Tejani-Butt SM, Yang J, Pawlyk AC. Altered serotonin transporter sites in Alzheimer’s disease raphe and hippocampus. Neuroreport. 1995;6:1207–1210

PII: S0165-0327(02)00021-6

doi: 10.1016/S0165-0327(02)00021-6

Journal of Affective Disorders
Volume 75, Issue 1 , Pages 65-69 , June 2003